UNIFY - Research and Innovation Unit of Radiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Oncology, Odense University Hospital, Odense, Denmark.
BMJ Case Rep. 2023 Oct 19;16(10):e256256. doi: 10.1136/bcr-2023-256256.
This case presents CT-guided percutaneous cryoablation as a treatment option in a patient with oligometastatic breast cancer who previously had received standard-of-care treatment for metastatic breast cancer. Before cryoablation, the patient received two systemic lines of therapy, several surgeries and radiotherapy for oligometastatic disease. The cryoablation was performed in a single 7 mm subpleural oligometastatic lesion 42 months after diagnosis of metastatic breast cancer. It was performed without complications, and the patient experienced no complaints or discomfort after the procedure. A 3-month, 6-month, 9-month and 12-month follow-up fluorodeoxyglucose-positron emission tomography/CT scans showed no sign of disease progression.
本病例介绍了 CT 引导下经皮冷冻消融作为治疗选择，适用于先前接受转移性乳腺癌标准治疗的寡转移乳腺癌患者。冷冻消融前，患者接受了二线全身治疗、针对寡转移疾病的多次手术和放疗。冷冻消融在转移性乳腺癌诊断后 42 个月进行，在一个 7mm 胸膜下寡转移病变中进行。手术无并发症，患者术后无不适或不适。3 个月、6 个月、9 个月和 12 个月的氟脱氧葡萄糖正电子发射断层扫描/CT 随访未显示疾病进展迹象。
